|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：S199175 |
| 產(chǎn)品名稱：Schizandrol B |
| 產(chǎn)品CAS：58546-54-6 |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
S199175 |
| 名稱: |
Schizandrol B |
| 別名: |
5,6,7,8-Tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-benzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-6-ol Stereoisomer; (6S,7S,13aR)-5,6,7,8-Tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethylbenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-6-ol; (+)-Gomisin A; Besigomsin; Gomisin A; Schisandrol B; Schisantherinol B; TJN 101; Wuweizi alcohol B; Wuweizichun B; |
| CAS號: |
58546-54-6 |
| 分子式: |
C??H??O? |
| 分子量: |
416.46 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Schizandrol B exhibits potent protective effects of on ET-1-induced dysfunctional human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs). Anti-cholestasis effect. |
| 參考文獻 |
|
|
|
|
?您的位置：
